TY - JOUR
T1 - Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US
AU - Mhaimeed, Omar
AU - Pillai, Krishnadev
AU - Dargham, Soha
AU - Al Suwaidi, Jassim
AU - Jneid, Hani
AU - Abi Khalil, Charbel
N1 - Publisher Copyright:
2023 Mhaimeed, Pillai, Dargham, Al Suwaidi, Jneid and Abi Khalil.
PY - 2023
Y1 - 2023
N2 - Aims: We aimed to assess the impact of diabetes on sudden cardiac arrest (SCA) in US patients hospitalized for ST-elevation myocardial infarction (STEMI). Methods: We used the National Inpatient Sample (2005–2017) data to identify adult patients with STEMI. The primary outcome was in-hospital SCA. Secondary outcomes included in-hospital mortality, ventricular tachycardia (VT), ventricular fibrillation (VF), cardiogenic shock (CS), acute renal failure (ARF), and the revascularization strategy in SCA patients. Results: SCA significantly increased from 4% in 2005 to 7.6% in 2018 in diabetes patients and from 3% in 2005 to 4.6% in 2018 in non-diabetes ones (p < 0.001 for both). Further, diabetes was associated with an increased risk of SCA [aOR = 1.432 (1.336–1.707)]. In SCA patients with diabetes, the mean age (SD) decreased from 68 (13) to 66 (11) years old, and mortality decreased from 65.7% to 49.3% during the observation period (p < 0.001). Compared to non-diabetes patients, those with T2DM had a higher adjusted risk of mortality, ARF, and CS [aOR = 1.72 (1.62–1.83), 1.52 (1.43–1.63), 1.25 (1.17–1.33); respectively] but not VF or VT. Those patients were more likely to undergo revascularization with CABG [aOR = 1.197 (1.065–1.345)] but less likely to undergo PCI [aOR = 0.708 (0.664–0.754)]. Conclusion: Diabetes is associated with an increased risk of sudden cardiac arrest in ST-elevation myocardial infarction. It is also associated with a higher mortality risk in SCA patients. However, the recent temporal mortality trend in SCA patients shows a steady decline, irrespective of diabetes.
AB - Aims: We aimed to assess the impact of diabetes on sudden cardiac arrest (SCA) in US patients hospitalized for ST-elevation myocardial infarction (STEMI). Methods: We used the National Inpatient Sample (2005–2017) data to identify adult patients with STEMI. The primary outcome was in-hospital SCA. Secondary outcomes included in-hospital mortality, ventricular tachycardia (VT), ventricular fibrillation (VF), cardiogenic shock (CS), acute renal failure (ARF), and the revascularization strategy in SCA patients. Results: SCA significantly increased from 4% in 2005 to 7.6% in 2018 in diabetes patients and from 3% in 2005 to 4.6% in 2018 in non-diabetes ones (p < 0.001 for both). Further, diabetes was associated with an increased risk of SCA [aOR = 1.432 (1.336–1.707)]. In SCA patients with diabetes, the mean age (SD) decreased from 68 (13) to 66 (11) years old, and mortality decreased from 65.7% to 49.3% during the observation period (p < 0.001). Compared to non-diabetes patients, those with T2DM had a higher adjusted risk of mortality, ARF, and CS [aOR = 1.72 (1.62–1.83), 1.52 (1.43–1.63), 1.25 (1.17–1.33); respectively] but not VF or VT. Those patients were more likely to undergo revascularization with CABG [aOR = 1.197 (1.065–1.345)] but less likely to undergo PCI [aOR = 0.708 (0.664–0.754)]. Conclusion: Diabetes is associated with an increased risk of sudden cardiac arrest in ST-elevation myocardial infarction. It is also associated with a higher mortality risk in SCA patients. However, the recent temporal mortality trend in SCA patients shows a steady decline, irrespective of diabetes.
KW - ST elevation myocardial infarction
KW - cardiovascular disease
KW - diabetes
KW - mortality
KW - sudden cardiac arrest
UR - http://www.scopus.com/inward/record.url?scp=85165177892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165177892&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2023.1175731
DO - 10.3389/fcvm.2023.1175731
M3 - Article
C2 - 37465457
AN - SCOPUS:85165177892
SN - 2297-055X
VL - 10
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1175731
ER -